Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Heterogeneity of IPF exacerbations.

Journal article

Ramakrishnan S. and Bafadhel M., (2022), Lancet Respir Med, 10

Antibiotics for asthma attacks: masking uncertainty.

Journal article

Ramakrishnan S. and Couillard S., (2021), The European respiratory journal, 58

Inhaled budesonide for early treatment of COVID-19 - Authors' reply.

Journal article

Ramakrishnan S. and Bafadhel M., (2021), The Lancet. Respiratory medicine

Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma

Journal article

Crossingham I. et al, (2021), Cochrane Database of Systematic Reviews

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial

Journal article

Yu L-M. et al, (2021)

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Journal article

Ramakrishnan S. et al, (2021), The Lancet Respiratory Medicine

Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus

Journal article

Ramakrishnan S. et al, (2021), International Journal of Chronic Obstructive Pulmonary Disease, Volume 16, 321 - 332

Biomarkers in COPD

Chapter

Ramakrishnan S. and Bafadhel M., (2021), Reference Module in Biomedical Sciences

Reply to Lipworth et al.: Don’t Forget about Facilitatory Effects of Corticosteroids on β2-Adrenoceptors in Acute Asthma

Journal article

Moran AM. et al, (2020), American Journal of Respiratory and Critical Care Medicine, 202, 1743 - 1744

Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma

Journal article

Moran AM. et al, (2020), American Journal of Respiratory and Critical Care Medicine, 202, 1314 - 1316

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma

Conference paper

Moran A. et al, (2020), EUROPEAN RESPIRATORY JOURNAL, 56

European expert consensus on assessment and management of hospitalised exacerbations of COPD (CICERO ERS CRC)

Conference paper

Ramakrishnan S. et al, (2020), EUROPEAN RESPIRATORY JOURNAL, 56

The Use of Benralizumab in the Treatment of Near-Fatal Asthma: A New Approach

Journal article

Ramakrishnan S. et al, (2020), American Journal of Respiratory and Critical Care Medicine, 201, 1441 - 1443

Chronic obstructive pulmonary disease: management of chronic disease

Journal article

Ramakrishnan S. et al, (2020), Medicine, 48, 333 - 336

The CICERO (Collaboration In COPD ExaceRbatiOns) Clinical Research Collaboration.

Conference paper

Janssens W. et al, (2020), The European respiratory journal, 55

Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma

Journal article

Crossingham I. et al, (2020), Cochrane Database of Systematic Reviews

Is it time to give up on “self-management” of COPD exacerbations?

Journal article

Ramakrishnan S. and Bafadhel M., (2020), European Respiratory Journal, 55